Early research (Phase 1)Study completedNCT02029313
What this trial is testing
Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma
Who this might be right for
Asthma and Allergic Rhinitis
PharmaKing 40